v


Global First: Ruijin Hospital Shanghai Successfully Performs Perineal Urethral Cancer Radical Surgery Using SHURUI® Single-Port Surgical Robot

 

Ruijin Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, recently achieved a groundbreaking milestone. Led by Director Junwei Pan, the urology team completed the world’s first perineal urethral cancer radical surgery assisted by the innovative SHURUI® single-port surgical robot. This pioneering procedure opens a new chapter in robotic perineal surgery, offering urethral cancer patients a minimally invasive treatment alternative.

 

Urethral cancer, a rare malignancy in the urinary system, poses surgical challenges due to complex anatomy and limited operating space. Traditional open surgery often involves large incisions, difficult exposure, and restricted instrument maneuverability, causing greater trauma and longer recovery.

 

Utilizing the SHURUI® robot’s flexible snake-arm technology and 10x magnified 3D vision, Director Pan precisely dissected and removed cancerous tissue through a single small incision. This breakthrough not only elevates robotic-assisted urethral cancer treatment but also demonstrates potential applications in breast, ENT, and other traditionally open surgeries.

 

This achievement highlights China’s leadership in advanced minimally invasive robotic surgery, redefining standards with safer, more efficient, and patient-friendly approaches.

 

Important Notes

The Single-port Endoscopic Surgical System (SR-ENS-600), developed and produced by Beijing Surgerii Robotics Company Limited, has been approved by the National Medical Products Administration (NMPA) in China for urology and gynecology laparoscopic surgeries. Surgeons who wish to learn the surgical operations of the SHURUI robot should contact Beijing Surgerii Robotics Co., Ltd. to participate in the official training program. Patients who want to participate in the registered clinical trials of the SHURUI robot should contact the official cooperative hospitals of Surgerii and consult with surgeons to determine their suitability for surgery with the SHURUI robot. Both surgeons and patients should carefully understand all information regarding the performance of surgeries by the SHURUI robot and its potential risks.


Beijing Surgerii Robotics Co., Ltd. owns Surgerii®, SHURUI®, and other trademarks and may not be used without permission.